Inventor · disambiguated record
Saisai Zhao
Also filed as: ZHAO SAISAI
2 granted patents·8 pending applications·1 citations·filing 2021–2025
32Inventor score
Files withHENAN MEDINNO PHARMACEUTICAL TECH CO LTD6MEDINNO PHARMACEUTICAL TECH ZHUHAI CO LTD3SHENZHEN KANGSU PHARMACEUTICAL TECH CO LTD1
Top patents by PatentIndex Score
10 records- 0174US11629148B2Substituted pyrrolo[3,4-d]imidazoles as JAK inhibitorsHENAN MEDINNO PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Apr 18, 2023·1 cites·16 claims
- 0258US12180215B2Substituted pyrrolo[3,4-d]imidazoles as JAK inhibitorsHENAN MEDINNO PHARMACEUTICAL TECH CO LTD·Filed 2023·Granted Dec 31, 2024·0 cites·19 claims
- 0353US2023374025A1Fgfr inhibitor compound and use thereofSHENZHEN KANGSU PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0453US2025387388A1Compound as trk inhibitor and/or ret inhibitor and use thereofMEDINNO PHARMACEUTICAL TECH ZHUHAI CO LTD·Filed 2023·Application pending·0 cites
- 0553US2025215017A1TGF-ß INHIBITOR COMPOUND AND USE THEROFMEDINNO PHARMACEUTICAL TECH ZHUHAI CO LTD·Filed 2025·Application pending·0 cites
- 0652US2025179094A1Tgf-b inhibitor compound and use thereofMEDINNO PHARMACEUTICAL TECH ZHUHAI CO LTD·Filed 2025·Application pending·0 cites
- 0749US2024317760A1Trk kinase inhibitor compound and use thereofHENAN MEDINNO PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0848US2023201165A1Jak inhibitor compound for treating severe pneumoniaHENAN MEDINNO PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0942US2023192710A1Jak inhibitor compound and use thereofHENAN MEDINNO PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 1040US2023192656A1Fgfr inhibitor compound and use thereofHENAN MEDINNO PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Saisai Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →